| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/25/2014 | US20140377364 Active ingredient delivery system |
| 12/25/2014 | US20140377363 1-[2-(2,4-Dimethylphenylsulfanyl)-Phenyl]Piperazine As A Compound With Combined Serotonin Reuptake, 5-HT3 And 5-HT1a Activity For The Treatment Of Cognitive Impairment |
| 12/25/2014 | US20140377361 Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery |
| 12/25/2014 | US20140377358 Nanoparticulate formulation comprising a trpa1 antagonist |
| 12/25/2014 | US20140377357 Poloxamer Based Inhalation Composition |
| 12/25/2014 | US20140377356 Inhalation Composition for Treating Respiratory Tract Infections |
| 12/25/2014 | US20140377355 Levofloxacin Inhalation Composition |
| 12/25/2014 | US20140377353 Pharmaceutical product to induce endogenous exacerbated release of gut hormones pyy and glp1 with therapeutic effect on obesity and type 2 diabetes mellitus |
| 12/25/2014 | US20140377352 Abuse resistant forms of extended release morphine, method of use and method of making |
| 12/25/2014 | US20140377351 Method and composition for enhancing cognition in alzheimer's patients |
| 12/25/2014 | US20140377350 Bilayer tablet formulations of flurbiprofen and glucosamin |
| 12/25/2014 | US20140377349 Controlled release oral dosage form comprising oxycodone |
| 12/25/2014 | US20140377348 Controlled release hydrocodone formulations |
| 12/25/2014 | US20140377347 In-situ multilayered tablet technology |
| 12/25/2014 | US20140377346 Bosentan controlled release oral preparation |
| 12/25/2014 | US20140377345 Controlled release oral pharmaceutical dosage forms comprising mgbg |
| 12/25/2014 | US20140377343 Formulations of flurbiprofen and diacerein |
| 12/25/2014 | US20140377342 Wafer and capsule formulations with enhanced dissolution rates for fenofibrate |
| 12/25/2014 | US20140377339 Tusc2 therapies |
| 12/25/2014 | US20140377337 Transdermal application of prostaglandin e1 for the treatment of ocular ischemia |
| 12/25/2014 | US20140377336 Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem and cancer stem cells including glioblastoma multiforme and medulloblastoma |
| 12/25/2014 | US20140377335 Ophthalmic formulation |
| 12/25/2014 | US20140377330 Bioactive Hydrogel |
| 12/25/2014 | US20140377329 Sublingual films |
| 12/25/2014 | US20140377328 Intraoral soluble-type film preparation |
| 12/25/2014 | US20140377327 Extended release drug-delivery contact lenses and methods of making |
| 12/25/2014 | US20140377322 Multi-layered structure for drug reservoir and drug eluting stent including the same |
| 12/25/2014 | US20140377312 Transmucosal Administration System for a Pharmaceutical Drug |
| 12/25/2014 | US20140377307 Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities |
| 12/25/2014 | US20140377304 Treatment and composition for achieving skin anti-aging benefits by corneum protease activation |
| 12/25/2014 | US20140377293 Methods for treating newly diagnosed multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with dexamethasone |
| 12/25/2014 | US20140377289 Metallodrugs Having Improved Pharmacological Properties, and Methods of Manufacture and Use Thereof |
| 12/25/2014 | US20140377285 Treatment regimens using multiple pharmaceutical agents |
| 12/25/2014 | US20140377274 Use of 2-deoxy-d-glucose to sensitize cancer cells to an agent that activates the extrinsic apoptotic pathway |
| 12/25/2014 | US20140377265 Anticoagulant antidotes |
| 12/25/2014 | US20140377263 Let-7 microrna and mimetics thereof as therapeutics for cancer |
| 12/25/2014 | US20140377259 Methods for inhibiting hiv-1 replication involving the administration of an anti-ccr5 receptor monoclonal antibody and small molecule ccr5 receptor antagonist |
| 12/25/2014 | US20140377258 Treatment Of Cancers Using PI3 Kinase Isoform Modulators |
| 12/25/2014 | US20140377257 Combination therapy for b cell disorders |
| 12/25/2014 | US20140377249 New pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers |
| 12/25/2014 | US20140377247 Benzamides and related inhibitors of factor xa |
| 12/25/2014 | US20140377242 Coenzyme q10-containing composition for oral ingestion |
| 12/25/2014 | US20140377235 Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions |
| 12/25/2014 | US20140377225 Methods of improving bone health and muscle health |
| 12/25/2014 | US20140377224 Method of Treating or Retarding the Development of Blindness |
| 12/25/2014 | US20140377223 Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases |
| 12/25/2014 | US20140377219 Hiv inhibitors |
| 12/25/2014 | US20140377214 Materials and methods to enhance hematopoietic stem cells engraftment procedures |
| 12/25/2014 | US20140377210 Artificial tear compositions |
| 12/25/2014 | US20140377190 Compositions, methods and systems for respiratory delivery of two or more active agents |
| 12/25/2014 | US20140377189 Pulmonary administration of rotigotine |
| 12/25/2014 | US20140377179 Compositions and methods for delivering inhibitory oligonucleotides |
| 12/25/2014 | US20140377176 Functionalised silicon nanoparticles |
| 12/25/2014 | US20140377174 Method for preparing cell targeting conjugates, and the complexes obtained |
| 12/25/2014 | US20140377168 Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin |
| 12/25/2014 | US20140373832 Inhaler comprising a tiotropium-containing-composition |
| 12/24/2014 | CN104245936A 用于抑制TGF-β2表达的shRNA For inhibiting the expression of shRNA TGF-β2 |
| 12/24/2014 | CN104245935A 三环硫代磷酸酯dna Tricyclic phosphorothioate dna |
| 12/24/2014 | CN104245800A 新苯聚羧酸化合物 The new compound benzene polycarboxylate |
| 12/24/2014 | CN104245718A 制备磺达肝素钠的方法及其合成中使用的中间体 Intermediate Preparation fondaparinux sodium heparin and synthetic methods used |
| 12/24/2014 | CN104245707A 抗血栓化合物 Antithrombotic compound |
| 12/24/2014 | CN104245706A Furofuran型木脂体化合物的制备方法 Preparation Furofuran type lignan compound |
| 12/24/2014 | CN104245705A 用于癌症治疗的6-(4-(1-氨基-3-羟基环丁基)苯基)-5-苯基(呋喃并、噻吩并、或吡咯并)[2, 3-d]嘧啶-4-酮衍生物 For cancer treatment 6- (4- (1-amino-3-hydroxy-cyclobutyl) phenyl) -5-phenyl (furo, thieno, or pyrrolo) [2, 3-d] pyrimidine - 4-one derivatives |
| 12/24/2014 | CN104245704A 取代的吡喃并和呋喃并喹啉,其制备和药物用途 And furan substituted pyrano and quinoline, their preparation and pharmaceutical use |
| 12/24/2014 | CN104245701A 有酪氨酸激酶抑制剂的组合产品和其应用 Tyrosine kinase inhibitor combination product and its Applications |
| 12/24/2014 | CN104245700A 二取代的苯并噻吩基-吡咯并三嗪及其作为fgfr激酶抑制剂的用途 Disubstituted benzothienyl - pyrrolotriazine kinase inhibitors and their use as fgfr |
| 12/24/2014 | CN104245698A 含氮杂环化合物 Nitrogen-containing heterocyclic compounds |
| 12/24/2014 | CN104245696A 作为1型二酰基甘油o-酰基转移酶的抑制剂的化合物 Type compounds as a diacylglycerol o- acyltransferase inhibitors |
| 12/24/2014 | CN104245695A 用于治疗病毒性感染的哌啶基-嘧啶衍生物 For the treatment of viral infections piperidinyl - pyrimidine derivative |
| 12/24/2014 | CN104245694A 具有治疗活性的氨基亚甲基吡唑啉酮 Therapeutically active aminomethylene pyrazolone |
| 12/24/2014 | CN104245688A 活化ampk的吲哚和吲唑类化合物 Activation of indole and indazole compounds ampk of |
| 12/24/2014 | CN104245681A (1,2,3-唑)磺酰衍生物 (1,2,3-yl) sulfonamide derivatives |
| 12/24/2014 | CN104245678A 用氯丙酮制备美托咪定的方法 Acetone with chlorine preparation method dexmedetomidine |
| 12/24/2014 | CN104245675A 作为MetAP-2抑制剂的环酰胺 As MetAP-2 inhibitor cyclic amide |
| 12/24/2014 | CN104245674A 新苯基-四氢异喹啉衍生物 New phenyl - tetrahydroisoquinoline derivative |
| 12/24/2014 | CN104245673A 5-[(1r)-2-({2-[4-(2,2-二氟-2-苯基乙氧基)苯基]乙基}氨基)-1-羟乙基]-8-羟基喹啉-2(1h)-酮的盐 5 - [(1r) -2 - ({2- [4- (2,2- difluoro-2-phenylethoxy) phenyl] ethyl} amino) -1-hydroxyethyl] -8 hydroxyquinoline -2 (1h) - -one salt |
| 12/24/2014 | CN104245671A 含氮杂环化合物或其盐 Nitrogen-containing heterocyclic compounds or salts thereof |
| 12/24/2014 | CN104245669A 异吲哚啉衍生物、含有其的药物组合物及其在治疗中的用途 Isoindoline derivatives, pharmaceutical compositions containing them and their use in therapy |
| 12/24/2014 | CN104245663A 二环化合物 Bicyclic compound |
| 12/24/2014 | CN104244988A 结合治疗活性剂的聚合物、其制备方法以及其用途 Polymer active agent combination therapy, their preparation and their use |
| 12/24/2014 | CN104244986A 可控释的药物递送缀合物及其应用 Controlled release drug delivery conjugates and their application |
| 12/24/2014 | CN104244983A 控制释放组合物及其使用方法 Controlled release composition and method of use |
| 12/24/2014 | CN104244982A 酪氨酸激酶抑制剂组合及其用途 Tyrosine kinase inhibitors and their use in combination |
| 12/24/2014 | CN104244968A Ph20多肽变体、配制物及其应用 Ph20 polypeptide variant, formulation and application |
| 12/24/2014 | CN104244961A 松萝属地衣类提取物的制造方法 Usnea extract territorial clothing manufacturing method thereof |
| 12/24/2014 | CN104244960A 皮下组织及皮下脂肪组织增加促进用组合物 Increase in subcutaneous tissue and subcutaneous adipose tissue composition for promoting |
| 12/24/2014 | CN104244958A 改进的协同抗糖尿病组合物 Improved synergistic anti-diabetic composition |
| 12/24/2014 | CN104244957A 用于治疗分娩停止的方法 The method of treatment for stopping delivery |
| 12/24/2014 | CN104244956A 使用环糊精的方法 Method using cyclodextrin |
| 12/24/2014 | CN104244955A 用于增加吞咽效能的方法 Increase the effectiveness of methods for swallowing |
| 12/24/2014 | CN104244954A 具有电偶颗粒的止血材料和装置 Hemostatic material and means having galvanic particulates |
| 12/24/2014 | CN104244953A 用于治疗雄激素缺乏的联合治疗 Combination therapy for the treatment of androgen deficiency |
| 12/24/2014 | CN104244952A 组蛋白脱乙酰酶抑制剂与帕唑帕尼的组合及其用途 Histone deacetylase inhibitors in combination with pazopanib and their use |
| 12/24/2014 | CN104244951A 肽脱甲酰化酶抑制剂 Peptide inhibitors deformylation |
| 12/24/2014 | CN104244950A 含有西洛他唑及银杏叶提取物作为有效成分的听觉障碍预防或治疗用药物组合物 Hearing-impaired containing cilostazol and Ginkgo biloba extract as an active ingredient for preventing or treating a pharmaceutical composition |
| 12/24/2014 | CN104244949A 用于治疗神经母细胞瘤、尤文氏肉瘤或横纹肌肉瘤的化合物 For the treatment of neuroblastoma, Ewing's sarcoma, a compound or rhabdomyosarcoma |
| 12/24/2014 | CN104244948A 在炎症性疾病的治疗中使用的用于调节n-酰基乙醇胺的特异性酰胺酶的组合物和方法 Compositions and methods for use in the treatment of inflammatory diseases for adjusting n- acylethanolamines specific amidase |
| 12/24/2014 | CN104244947A 用于治疗hcv的方法和组合物 Method for the treatment and compositions hcv |
| 12/24/2014 | CN104244946A 新制剂 The new formulation |
| 12/24/2014 | CN104244945A 用于治疗hcv的方法 The method for treating hcv |